2024 Annual Meeting | S4 - Autoimmune Neurology: Autoimmune Encephalitis and Neuronal Autoantibodies
Program Materials Program Evaluations
| Soon-Tae Lee, MD, PhD | Prof. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Advanced Neural Technologies. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celltrion. The institution of Prof. Lee has received research support from Roche. The institution of Prof. Lee has received research support from Celltrion. Prof. Lee has received intellectual property interests from a discovery or technology relating to health care. |
| Sophie Binks | The institution of Ms. Binks has received research support from Wellcome Trust. The institution of Ms. Binks has received research support from PetSavers. The institution of Ms. Binks has received research support from PetPlan. The institution of Ms. Binks has received research support from NIHR. Ms. Binks has received intellectual property interests from a discovery or technology relating to health care. Ms. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with ECTRIMS. Ms. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with Vetmeduni Wien. Ms. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with ANA. Ms. Binks has a non-compensated relationship as a Speaker with Encephalitis Society UK that is relevant to AAN interests or activities. |
| Masashi Maeda | No disclosure on file |
| Atsuo Kanno | No disclosure on file |
| Satoshi Kubo | No disclosure on file |
| Shanni Yamaki | Shanni Yamaki has received personal compensation for serving as an employee of Arialys Therapeutics Inc. . |
| Roghiye Kazimi | Roghiye Kazimi has nothing to disclose. |
| Mitsuyuki Matsumoto, PhD | Dr. Matsumoto has received personal compensation for serving as an employee of Arialys Therapeutics, Inc.. Dr. Matsumoto has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Arialys Therapeutics, Inc.. Dr. Matsumoto has stock in Arialys Therapeutics, Inc.. Dr. Matsumoto has received intellectual property interests from a discovery or technology relating to health care. |
| Amir Razai | No disclosure on file |
| Vallari Eastman | No disclosure on file |
| Mathew Mitchell | Mr. Mitchell has received personal compensation for serving as an employee of Arialys Therapeutics. |
| Carrolee Barlow, MD, PhD | No disclosure on file |
| Jay Lichter, PhD | Dr. Lichter has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Janux. |
| Carol Swetlik, MD | An immediate family member of Dr. Swetlik has received personal compensation for serving as an employee of Pfizer. Dr. Swetlik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech. Dr. Swetlik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. |
| Nicholas Thompson | No disclosure on file |
| Vineet Punia, MD | Dr. Punia has nothing to disclose. |
| Albert Aboseif, DO | Dr. Aboseif has a non-compensated relationship as a AAN Autoimmune Neurology Section -- Education Workgroup with AAN that is relevant to AAN interests or activities. |
| Rachel Galioto | Rachel Galioto has nothing to disclose. |
| Amy Kunchok, MBBS | Dr. Kunchok has received personal compensation in the range of $0-$499 for serving as a Consultant for EMD Serono. Dr. Kunchok has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon therapeutics . Dr. Kunchok has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kunchok has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. |
| Sergio Muniz-Castrillo, MD, PhD | Dr. Muniz-Castrillo has nothing to disclose. |
| Vicente Peris Sempere | No disclosure on file |
| Louis Compérat | No disclosure on file |
| Anne-Laurie Pinto | No disclosure on file |
| Selina Yogeshwar, MSc | Miss Yogeshwar has received research support from Einstein Center for Neurosciences. |
| Bastien Joubert | No disclosure on file |
| Jerome Honnorat, MD, PhD | The institution of Jerome Honnorat, MD, PhD has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for journal of neurology. |
| Emmanuel Mignot, MD, PhD | Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuticals, Inc. . Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for EcoR1. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for ApneaCo. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai Pharmaceuticals. Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Centessa . |
| Katherine E. Lewis, PhD | Katherine E. Lewis, PhD has received personal compensation for serving as an employee of Alpine Immune Sciences. Katherine E. Lewis, PhD has stock in Alpine Immune Sciences. |
| ZAHRA MARIA | No disclosure on file |
| Luana Griffin | No disclosure on file |
| Joel Lenox | No disclosure on file |
| Ningxin Wang | No disclosure on file |
| Stacey Dillon | No disclosure on file |
| Stanford Peng, MD, PhD | Dr. Peng has received personal compensation for serving as an employee of Alpine Immune Sciences. |
| Smathorn Thakolwiboon, MD | Dr. Thakolwiboon has nothing to disclose. |
| Emma J. Orozco, MD | Dr. Orozco has nothing to disclose. |
| Michael Gilligan, MBBS | Dr. Gilligan has received intellectual property interests from a discovery or technology relating to health care. |
| Jeffrey W. Britton, MD, FAAN | Dr. Britton has received personal compensation in the range of $0-$499 for serving as a Online course with American Clinical Neurophysiology Society. |
| Divyanshu Dubey, MD, FAAN | The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. |
| Eoin P. Flanagan, MBBCh, FAAN | The institution of Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from Viela Bio. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. |
| Nicholas L. Zalewski, MD | Dr. Zalewski has nothing to disclose. |
| Alfonso S. Lopez, MD | Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . |
| Cristina Valencia Sanchez, MD | Dr. Valencia Sanchez has nothing to disclose. |
| Anastasia Zekeridou, MD, PhD, FAAN | The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. |
| Sean J. Pittock, MD | Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech, Inc.. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics, Inc.. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prime Therapeutics. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedImmune/Viela Bio. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB, Inc. Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman/LaRoche AG. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hofman/LaRoche. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. The institution of Dr. Pittock has received research support from Grifols. The institution of Dr. Pittock has received research support from NIH. The institution of Dr. Pittock has received research support from Viela Bio/MedImmune/Horizon. The institution of Dr. Pittock has received research support from Alexion Pharmaceuticals. The institution of Dr. Pittock has received research support from F. Hoffman/LaRoche/Genentech. The institution of Dr. Pittock has received research support from NovelMed. The institution of Dr. Pittock has received research support from AstaZeneca. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care. |
| Andrew McKeon, MD | The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care. |
| Anna Kolchinski | Ms. Kolchinski has nothing to disclose. |
| Margaret Li | No disclosure on file |
| Ralph Habis, MD | Dr. Habis has nothing to disclose. |
| John Probasco, MD, FAAN | Dr. Probasco has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch Neurology. The institution of Dr. Probasco has received research support from Roche/Genentech. |
| Rodrigo Hasbun | No disclosure on file |
| Arun Venkatesan, MD, PhD | Dr. Venkatesan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. The institution of Dr. Venkatesan has received research support from NIH. The institution of Dr. Venkatesan has received research support from MSRCF. The institution of Dr. Venkatesan has received research support from U.S. DOD. |
| Jodie Roberts, MD | An immediate family member of Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx Pharmaceuticals. Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Roberts has received research support from Canadian Network of MS Clinics. Dr. Roberts has received research support from Rebecca Hotchkiss International Exchange Program. The institution of Dr. Roberts has received research support from University of Calgary Medical Group Helios Award. Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Novartis. Dr. Roberts has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with EMD Serono. |
| Christopher Hahn, MD | Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anylim. |
| Megan A. Yaraskavitch, MD | Dr. Yaraskavitch has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Allergan, an AbbVie Company. |
| Jamie Greenfield | No disclosure on file |
| Kisekka A. Musubire, MBBS | Dr. Musubire has nothing to disclose. |
| Kristoffer E. Leon, MD, PhD | Dr. Leon has nothing to disclose. |
| David Meya | No disclosure on file |
| David R. Boulware, MD, MPH | The institution of David R. Boulware, MD, MPH has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sfunga. David R. Boulware, MD, MPH has received publishing royalties from a publication relating to health care. David R. Boulware, MD, MPH has received personal compensation in the range of $0-$499 for serving as a Study Section with NIH. |
| Paul Bohjanen | No disclosure on file |
| Patrick Cras, MD, PhD | The institution of Dr. Cras has received research support from Belgian Fund for Scientific Research. Dr. Cras has received personal compensation in the range of $0-$499 for serving as a member with National Bioethics Committee. |
| Barbara Willekens, MD, PhD, FAAN | The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall . The institution of Dr. Willekens has received research support from Roche. The institution of Dr. Willekens has received research support from Janssen. Dr. Willekens has a non-compensated relationship as a Co-chair scientific panel of neuroimmunology with European Academy of Neurology that is relevant to AAN interests or activities. |
| Michael R. Wilson, MD, FAAN | Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Delve Bio. Dr. Wilson has stock in Delve Bio. The institution of Dr. Wilson has received research support from Genentech / Roche. The institution of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from UCSF Weill Institute for Neurosciences. The institution of Dr. Wilson has received research support from Novartis. The institution of Dr. Wilson has received research support from National Multiple Sclerosis Society. The institution of Dr. Wilson has received research support from Fanconi Anemia Research Foundation. The institution of Dr. Wilson has received research support from Department of Defense. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Witness with US Dept of Justice. |
| Julien Hebert, MD | Dr. Hebert has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Paladin Labs. |
| Lucy Jia | Ms. Jia has nothing to disclose. |
| Hyunmi Choi, MD | The institution of Dr. Choi has received research support from National Institute of Aging. |
| Kiran Thakur, MD, FAAN | The institution of Dr. Thakur has received research support from Center for Disease Control and Prevention. |
| Hai Ethan Hoang, MD | Dr. Hoang has nothing to disclose. |
| Donald Langan, Jr., MD | Dr. Langan has nothing to disclose. |
| William T. Harris II, MD | Dr. Harris has stock in Eli Lilly and Co. Dr. Harris has stock in Glaxo Smith Kline. |
| Safa Kaleem, MD | Dr. Kaleem has nothing to disclose. |
| John Budrow | No disclosure on file |
| Pallavi Juneja, MD | Dr. Juneja has nothing to disclose. |
| Jieru Egeria Lin, MD, PhD | Dr. Lin has nothing to disclose. |
| Alexander Sandweiss, MD, PhD | Dr. Sandweiss has nothing to disclose. |
| Varun Kannan, MD | Dr. Kannan has nothing to disclose. |
| Jonathan Yarimi, MD | Dr. Yarimi has nothing to disclose. |
| Jesse Levine, MD, PhD | Dr. Levine has nothing to disclose. |
| Kristen Fisher, DO | Dr. Fisher has nothing to disclose. |
| Stephen Kralik | No disclosure on file |
| Nilesh Desai | No disclosure on file |